Endocrinology — MCQs

A 40-year-old man presents with nausea, vomiting, diarrhea, and cramping abdominal pain. His temperature is 38°C, blood pressure is 90/60 mm Hg, and pulse rate is 90/minute. Physical examination reveals dehydration with sunken eyeballs, dry tongue, and poor skin turgor. Hyperpigmentation is noted in the palmar creases and the gingival margins. Laboratory results include fasting serum glucose of 62 mg/dL, BUN of 27 mg/dL, Na of 122 mEq/L, and K of 6.5 mEq/L. What is the most likely cause of this patient's symptoms?

Q14Easy

A 59-year-old man with type 2 diabetes presents for a screening eye examination. The ophthalmologist reports the development of non-proliferative retinopathy. For this patient with a complication of diabetes, select the most likely findings.

Q15Medium

A 20-year-old girl presents with a 9-month history of neck swelling and thyrotoxicosis symptoms. Investigations revealed increased T4 and decreased TSH with a palpable 2 cm nodule. What is the next investigation?

Q16Easy

Which of the following statements about Cushing's disease is true?

Q17Medium

A patient presents with bilateral proptosis, heat intolerance, and palpitations. Which of the following is the most unlikely diagnosis?

Q18Easy

Which of the following symptoms is NOT typically seen in hyponatremia?

Q19Easy

Which drug is used in the management of severe hypercalcemia?

Q20Easy

Syndrome X is not found in which of the following?

Endocrinology Indian Medical PG Practice Questions and MCQs

Question 11: Which diagnostic procedure is not typically performed in cases of pheochromocytoma?

A. CT scan
B. MRI
C. Fine Needle Aspiration Cytology (FNAC) (Correct Answer)
D. MIBG scan

Explanation: **Explanation:** The correct answer is **C. Fine Needle Aspiration Cytology (FNAC)**. In cases of suspected pheochromocytoma, FNAC is strictly **contraindicated**. This is because the mechanical trauma of the needle can trigger a massive, uncontrolled release of catecholamines from the tumor. This "catecholamine storm" can lead to a life-threatening hypertensive crisis, cardiac arrhythmias, or hemorrhage within the tumor. Diagnosis is primarily biochemical (metanephrines) followed by imaging; biopsy is never required for diagnosis and is dangerous. **Why other options are incorrect:** * **A. CT Scan:** This is the initial imaging modality of choice for localizing the tumor due to its excellent spatial resolution. Pheochromocytomas typically appear as hypervascular masses with high attenuation (>10 HU) on non-contrast CT. * **B. MRI:** Highly sensitive for detecting pheochromocytomas. On T2-weighted images, these tumors often exhibit a characteristic "light bulb" appearance (hyperintensity). MRI is preferred in children, pregnant women, or patients with contrast allergies. * **D. MIBG Scan:** Metaiodobenzylguanidine (MIBG) is a functional imaging study used to detect extra-adrenal (paragangliomas) or metastatic disease that may be missed by CT/MRI. **High-Yield Clinical Pearls for NEET-PG:** * **Rule of 10s:** 10% are bilateral, 10% are malignant, 10% are extra-adrenal, and 10% are familial. * **Biochemical Screening:** 24-hour urinary fractionated metanephrines or plasma free metanephrines are the first-line tests. * **Pre-operative Management:** Always start **Alpha-blockers first** (e.g., Phenoxybenzamine) followed by Beta-blockers to avoid an unopposed alpha-mediated hypertensive crisis.

Question 12: Which of the following statements regarding obesity syndromes are true or false?

A. Prader-Willi syndrome has normal stature with truncal obesity; Laurence-Moon-Biedl is autosomal with polydactyly; Ahlstrom's syndrome patients have moderate mental retardation; Cohen's syndrome patients have craniofacial anomalies and delayed puberty; Carpenter's syndrome have secondary hypogonadism are all true, except Prader-Willi syndrome and Ahlstrom's syndrome are false. (Correct Answer)
B. Prader-Willi syndrome has normal stature with truncal obesity; Laurence-Moon-Biedl is autosomal with polydactyly; Ahlstrom's syndrome patients have moderate mental retardation; Cohen's syndrome patients have craniofacial anomalies and delayed puberty; Carpenter's syndrome have secondary hypogonadism are all true, except Laurence-Moon-Biedl is false.
C. Prader-Willi syndrome has normal stature with truncal obesity; Laurence-Moon-Biedl is autosomal with polydactyly; Ahlstrom's syndrome patients have moderate mental retardation; Cohen's syndrome patients have craniofacial anomalies and delayed puberty; Carpenter's syndrome have secondary hypogonadism are all true, except Prader-Willi syndrome is false.
D. Prader-Willi syndrome has normal stature with truncal obesity; Laurence-Moon-Biedl is autosomal with polydactyly; Ahlstrom's syndrome patients have moderate mental retardation; Cohen's syndrome patients have craniofacial anomalies and delayed puberty; Carpenter's syndrome have secondary hypogonadism are all true, except Prader-Willi syndrome and Carpenter's syndrome are false.

Explanation: This question tests the ability to differentiate between various genetic syndromes associated with obesity, a high-yield area for NEET-PG. [1] ### **Analysis of the Statements** 1. **Prader-Willi Syndrome (PWS):** Characterized by **short stature** (due to GH deficiency), hypotonia, and hyperphagia. The statement claiming "normal stature" is **False**. [1] 2. **Alström Syndrome:** Features include childhood obesity, type 2 diabetes, and sensory loss (blindness/deafness). Crucially, intelligence is usually **normal**. The statement claiming "moderate mental retardation" is **False**. 3. **Laurence-Moon-Bardet-Biedl Syndrome:** An autosomal recessive condition characterized by obesity, **polydactyly**, retinitis pigmentosa, and hypogonadism. This is **True**. [1] 4. **Cohen’s Syndrome:** Characterized by obesity, **craniofacial dysmorphism** (prominent incisors), and **delayed puberty**. This is **True**. 5. **Carpenter’s Syndrome:** An autosomal recessive acrocephalopolysyndactyly syndrome featuring craniosynostosis, obesity, and **hypogonadism**. This is **True**. ### **Why Option A is Correct** Option A correctly identifies that while the descriptions for Laurence-Moon-Biedl, Cohen’s, and Carpenter’s syndromes are accurate, the descriptions for **Prader-Willi** (should be short stature) and **Alström** (should be normal intelligence) are **False**. ### **Why Other Options are Incorrect** * **Options B & C:** These are incomplete because they fail to recognize that *both* Prader-Willi and Alström statements contain factual errors. * **Option D:** Incorrectly suggests Carpenter’s syndrome description is false; however, hypogonadism is a recognized feature of this syndrome. ### **High-Yield Clinical Pearls for NEET-PG** * **Prader-Willi Syndrome:** Most common genetic cause of obesity; caused by absence of expression of the **paternal** copy of chromosome 15q11-q13. * **Bardet-Biedl vs. Alström:** Both have obesity and retinal degeneration, but **polydactyly** is specific to Bardet-Biedl. * **Alström Syndrome:** Think of it as "Obesity + Sensory loss + Normal IQ."

Question 13: A 40-year-old man presents with nausea, vomiting, diarrhea, and cramping abdominal pain. His temperature is 38°C, blood pressure is 90/60 mm Hg, and pulse rate is 90/minute. Physical examination reveals dehydration with sunken eyeballs, dry tongue, and poor skin turgor. Hyperpigmentation is noted in the palmar creases and the gingival margins. Laboratory results include fasting serum glucose of 62 mg/dL, BUN of 27 mg/dL, Na of 122 mEq/L, and K of 6.5 mEq/L. What is the most likely cause of this patient's symptoms?

A. Amyloidosis
B. Autoimmunity (Correct Answer)
C. Metastatic cancer
D. Sarcoidosis

Explanation: **Explanation:** The clinical presentation of hypotension, dehydration, hypoglycemia, hyponatremia, and hyperkalemia, combined with hyperpigmentation, is classic for **Primary Adrenal Insufficiency (Addison’s Disease)** [2]. The patient is currently in an **Addisonian Crisis**, likely precipitated by an acute stressor [1]. 1. **Why Autoimmunity is Correct:** In developed countries and increasingly in urban India, **Autoimmune Adrenalitis** (either isolated or as part of Polyglandular Autoimmune Syndromes) is the **most common cause** of primary adrenal insufficiency (responsible for ~80% of cases) [3]. It involves the destruction of the adrenal cortex, leading to a deficiency of cortisol (causing hypoglycemia and hypotension) and aldosterone (causing hyponatremia and hyperkalemia). The hyperpigmentation occurs because low cortisol triggers a compensatory increase in ACTH; the precursor molecule (POMC) also produces Melanocyte-Stimulating Hormone (MSH). 2. **Why Incorrect Options are Wrong:** * **Amyloidosis and Sarcoidosis:** These are infiltrative diseases that can involve the adrenal glands, but they are rare causes of clinical adrenal insufficiency compared to autoimmunity. * **Metastatic Cancer:** While cancers (especially lung and breast) frequently metastasize to the adrenals, they rarely destroy >90% of the gland required to cause symptomatic insufficiency [3]. **NEET-PG High-Yield Pearls:** * **Most common cause worldwide:** Autoimmunity (formerly Tuberculosis). * **Most common cause in developing countries/India:** Tuberculosis (look for adrenal calcification on CT) [3]. * **Electrolyte Hallmark:** Hyponatremia + Hyperkalemia + Metabolic Acidosis (Non-gap). * **Diagnosis:** Best initial test is the **ACTH Stimulation Test** (Cosyntropin test) [1]. * **Management of Crisis:** Immediate IV fluids (Normal Saline) and high-dose **IV Hydrocortisone**. Do not wait for lab confirmation [1].

Question 14: A 59-year-old man with type 2 diabetes presents for a screening eye examination. The ophthalmologist reports the development of non-proliferative retinopathy. For this patient with a complication of diabetes, select the most likely findings.

A. Microaneurysms and hemorrhage (dot and blot) (Correct Answer)
B. Vitreous hemorrhage
C. Dilated veins
D. Open-angle glaucoma

Explanation: **Explanation:** Diabetic Retinopathy (DR) is a leading cause of blindness and is categorized into Non-Proliferative (NPDR) and Proliferative (PDR) stages. **Why Option A is Correct:** The earliest clinical sign of NPDR is the formation of **microaneurysms**, which appear as small red dots due to capillary wall outpouching [1]. As these capillaries leak or rupture within the deeper layers of the retina (inner nuclear and outer plexiform layers), they create **"dot and blot" hemorrhages**. Other features of NPDR include hard exudates (lipid leaks) and cotton wool spots (nerve fiber layer infarcts). **Analysis of Incorrect Options:** * **B. Vitreous hemorrhage:** This is a hallmark of **Proliferative Diabetic Retinopathy (PDR)** [1]. It occurs when fragile new vessels (neovascularization) bleed into the vitreous cavity [1]. * **C. Dilated veins:** While venous "beading" or loops can occur in severe NPDR, simple dilated veins are more characteristic of Central Retinal Vein Occlusion (CRVO) or early hypertensive changes rather than the primary screening finding for NPDR. * **D. Open-angle glaucoma:** While diabetics have a higher risk of glaucoma, it is a separate pathological entity and not a diagnostic feature of non-proliferative retinopathy. **High-Yield NEET-PG Pearls:** * **Earliest Sign:** Microaneurysms (seen on Fundus Fluorescein Angiography) [1]. * **NPDR vs. PDR:** The defining feature of PDR is **Neovascularization** (NVD/NVE) driven by VEGF [1]. * **Macular Edema:** Can occur at *any* stage of DR and is the most common cause of vision loss in NPDR [1]. * **Screening:** Type 2 DM patients need a fundus exam **at the time of diagnosis**, whereas Type 1 DM patients should be screened **5 years after diagnosis**.

Question 15: A 20-year-old girl presents with a 9-month history of neck swelling and thyrotoxicosis symptoms. Investigations revealed increased T4 and decreased TSH with a palpable 2 cm nodule. What is the next investigation?

A. Ultrasound (USG) of the thyroid
B. Thyroid scan (Correct Answer)
C. Radioactive iodine uptake
D. CT scan

Explanation: The patient presents with clinical and biochemical evidence of **hyperthyroidism** (↑T4, ↓TSH) associated with a **palpable thyroid nodule**. In the management of a thyroid nodule, the first step is always checking the serum TSH [1]. **1. Why Thyroid Scan is the correct answer:** When TSH is suppressed (low), the priority is to determine if the nodule is "functioning" (autonomously producing hormone) [1]. A **Thyroid Scan (Radionuclide Scanning)** using Technetium-99m or Iodine-123 is the gold standard for this [1][2]. * If the nodule is **"Hot"** (increased uptake), it confirms a Toxic Adenoma. Hot nodules are almost never malignant, so Fine Needle Aspiration (FNA) is not required [1]. * If the nodule is **"Cold"** (no uptake), the risk of malignancy is higher, and the next step would be USG-guided FNA [1]. **2. Why other options are incorrect:** * **A. Ultrasound (USG):** While USG is the first-line imaging for a *euthyroid* nodule, in a *hyperthyroid* patient, the functional status (Scan) takes precedence to avoid unnecessary biopsies of hot nodules [1]. * **C. Radioactive Iodine Uptake (RAIU):** This measures the percentage of iodine trapped by the *entire* gland to differentiate causes of thyrotoxicosis (e.g., Graves' vs. Thyroiditis) [2]. It does not provide the anatomical localization needed to evaluate a specific nodule. * **D. CT Scan:** CT is not used for the initial evaluation of thyroid function or nodules and can interfere with future radioiodine therapy due to iodinated contrast [3]. ### Clinical Pearls for NEET-PG * **Algorithm:** Low TSH → Thyroid Scan; Normal/High TSH → USG followed by FNA (based on TIRADS) [1]. * **Toxic Adenoma (Plummer Disease):** Usually presents as a single "Hot" nodule with suppression of the rest of the gland. * **Rule of Thumb:** "Hot" nodules are safe (benign); "Cold" nodules need biopsy [1].

Question 16: Which of the following statements about Cushing's disease is true?

A. Serum adrenocorticotropic hormone (ACTH) levels usually are high
B. A pituitary microadenoma usually is present (Correct Answer)
C. There is a low incidence of nonendocrine tumors
D. Suppression of cortisol production by the high-dose dexamethasone suppression test is a characteristic finding

Explanation: ### Explanation **Cushing’s Disease** refers specifically to hypercortisolism caused by an **ACTH-secreting pituitary adenoma**. It is the most common cause of endogenous Cushing’s syndrome (excluding iatrogenic causes). **1. Why the Correct Answer is Right:** In approximately **90% of cases** of Cushing’s disease, the underlying cause is a **pituitary microadenoma** (defined as <10 mm in diameter). These tumors are typically located in the anterior pituitary and are composed of basophilic or chromophobe cells that autonomously secrete ACTH. **2. Analysis of Incorrect Options:** * **Option A:** Serum ACTH levels in Cushing’s disease are typically **normal to modestly elevated**, but not "high" (unlike Ectopic ACTH syndrome, where levels are markedly elevated). The key is that the ACTH is "inappropriately normal" in the presence of high cortisol. * **Option C:** There is actually an **increased incidence** of various tumors in patients with Cushing’s disease, and it can sometimes be part of **MEN 1 syndrome** (Multiple Endocrine Neoplasia type 1), which involves parathyroid and pancreatic tumors. * **Option D:** While Cushing’s disease *does* show suppression with the High-Dose Dexamethasone Suppression Test (HDDST), this is **not a universal characteristic finding** for all cases. Modern guidelines (like the Endocrine Society) prioritize IPSS (Inferior Petrosal Sinus Sampling) over HDDST because the latter has limited sensitivity and specificity in differentiating pituitary from ectopic sources. **Clinical Pearls for NEET-PG:** * **Gold Standard Investigation:** Inferior Petrosal Sinus Sampling (IPSS) is the most reliable method to differentiate Cushing’s disease from Ectopic ACTH syndrome. * **Initial Screening:** 24-hour urinary free cortisol, Low-dose dexamethasone suppression test (LDDST), or late-night salivary cortisol. * **Treatment of Choice:** Transsphenoidal surgery (TSS). * **Nelson’s Syndrome:** Rapid enlargement of a pituitary adenoma following bilateral adrenalectomy due to loss of negative feedback.

Question 17: A patient presents with bilateral proptosis, heat intolerance, and palpitations. Which of the following is the most unlikely diagnosis?

A. Hashimoto's thyroiditis
B. Thyroid adenoma
C. Diffuse thyroid goiter
D. Riedel's thyroiditis (Correct Answer)

Explanation: The patient presents with a classic triad of **hyperthyroidism** (heat intolerance, palpitations) and **Graves' ophthalmopathy** (bilateral proptosis) [1]. The question asks for the *most unlikely* diagnosis among the options provided. ### **Why Riedel’s Thyroiditis is the Correct Answer** **Riedel’s Thyroiditis** is a rare chronic inflammatory disease characterized by dense fibrous tissue replacing the thyroid parenchyma. Clinically, it presents as a "stony hard," fixed, painless goiter that often causes obstructive symptoms (callout). Crucially, patients are typically **hypothyroid** or euthyroid, and it is **never associated with proptosis**. ### **Analysis of Incorrect Options** * **Hashimoto’s Thyroiditis:** While typically causing hypothyroidism, it can present with a transient hyperthyroid phase known as **"Hashitoxicosis."** Furthermore, Hashimoto’s is associated with the same HLA alleles as Graves' disease; rarely, patients can have co-existing Graves' ophthalmopathy. * **Diffuse Thyroid Goiter:** This is the hallmark of **Graves' Disease**, the most common cause of hyperthyroidism [1]. Graves' is unique because it features extrathyroidal manifestations like bilateral proptosis due to TSH-receptor antibodies affecting orbital fibroblasts [1]. * **Thyroid Adenoma:** A hyperfunctioning (toxic) adenoma causes hyperthyroidism. While it doesn't cause autoimmune proptosis, it is a much more likely cause of the systemic symptoms (palpitations, heat intolerance) than Riedel’s. ### **NEET-PG High-Yield Pearls** * **Riedel’s Thyroiditis:** Associated with **IgG4-related systemic diseases** (e.g., retroperitoneal fibrosis, sclerosing cholangitis). * **Proptosis/Exophthalmos:** Specific to **Graves' Disease** (autoimmune) and not seen in other causes of thyrotoxicosis like Toxic Multinodular Goiter [1]. Treatment for severe inflammatory episodes may involve glucocorticoids or orbital radiotherapy [1]. * **Hard Thyroid Differential:** Riedel’s Thyroiditis vs. Anaplastic Carcinoma. Riedel’s is usually in younger patients and lacks the rapid malignant growth of anaplastic CA.

Question 18: Which of the following symptoms is NOT typically seen in hyponatremia?

A. Nausea
B. Delusion (Correct Answer)
C. Vomiting
D. Anorexia

Explanation: Hyponatremia (Serum Sodium <135 mEq/L) primarily manifests through gastrointestinal and neurological symptoms due to cerebral edema and increased intracranial pressure [1]. **Explanation of the Correct Answer:** **B. Delusion** is the correct answer because it is a fixed, false belief typically associated with primary psychiatric disorders (like schizophrenia) or chronic organic brain syndromes. While hyponatremia causes significant neurological impairment, it presents as **Delirium** (acute encephalopathy, confusion, or altered sensorium) rather than structured delusions. In severe cases, patients progress from lethargy and disorientation to seizures and coma, but not typically to isolated delusional thinking. **Explanation of Incorrect Options:** * **A & C. Nausea and Vomiting:** These are among the earliest and most common symptoms of hyponatremia [1]. They occur due to cerebral edema affecting the postrema (chemoreceptor trigger zone) and increased intracranial pressure. * **D. Anorexia:** Loss of appetite is a classic non-specific early symptom of electrolyte imbalance, particularly hyponatremia, often preceding more severe neurological decline. **High-Yield Clinical Pearls for NEET-PG:** 1. **Symptom Severity:** Symptoms depend more on the **rate of fall** of sodium rather than the absolute value. 2. **Neurological Spectrum:** Mild (130–135 mEq/L): Asymptomatic; Moderate (125–129 mEq/L): Nausea, headache, confusion; Severe (<125 mEq/L): Vomiting, seizures, somnolence, and coma. 3. **Osmotic Demyelination Syndrome (ODS):** Rapid correction of chronic hyponatremia (>10–12 mEq/L in 24 hours) can lead to Central Pontine Myelinolysis [2]. Remember: *"From Low to High, your Pons will die."* 4. **SIADH:** A common cause of euvolemic hyponatremia; look for low serum osmolality with inappropriately high urine osmolality (>100 mOsm/kg) [1].

Question 19: Which drug is used in the management of severe hypercalcemia?

A. Furosemide
B. Prednisolone
C. Pamidronate
D. All of the above (Correct Answer)

Explanation: **Explanation:** The management of severe hypercalcemia (typically defined as Serum Calcium >14 mg/dL) requires a multi-pronged approach aimed at increasing urinary excretion, inhibiting bone resorption, and addressing the underlying cause. **Why "All of the above" is correct:** 1. **Pamidronate (Bisphosphonates):** These are the **mainstay of treatment** for severe hypercalcemia, especially when malignancy-associated. They work by inhibiting osteoclast-mediated bone resorption. While they are highly effective, they have a delayed onset of action (24–72 hours). 2. **Furosemide (Loop Diuretics):** Once the patient is adequately rehydrated with IV Normal Saline, loop diuretics are used to promote "calciuresis" (urinary calcium excretion) by inhibiting the Na-K-2Cl symporter in the thick ascending limb of the Loop of Henle. *Note: Thiazides are contraindicated as they increase calcium reabsorption.* 3. **Prednisolone (Glucocorticoids):** These are specifically effective in hypercalcemia caused by Vitamin D toxicity, sarcoidosis, or lymphomas. They act by decreasing intestinal calcium absorption and inhibiting 1-alpha-hydroxylase activity. **Clinical Pearls for NEET-PG:** * **Immediate First Step:** The most crucial initial step in managing severe hypercalcemia is **aggressive IV hydration with 0.9% Normal Saline** to restore volume and enhance calcium excretion. * **Calcitonin:** Used for rapid reduction of calcium (works within hours) but is limited by **tachyphylaxis** (effect wears off after 48 hours). * **Cinacalcet:** A calcimimetic used specifically in secondary hyperparathyroidism (CKD) or parathyroid carcinoma. * **Denosumab:** A RANKL inhibitor used in refractory hypercalcemia of malignancy. * **Hemodialysis:** The treatment of choice for patients with severe hypercalcemia and concomitant heart failure or renal failure who cannot tolerate aggressive hydration.

Question 20: Syndrome X is not found in which of the following?

A. Diabetes Mellitus Type II
B. Dyslipidemia
C. High triglycerides
D. Weight loss (Correct Answer)

Explanation: Explanation: **Syndrome X**, now more commonly known as **Metabolic Syndrome** (or Insulin Resistance Syndrome), is a cluster of metabolic abnormalities that significantly increase the risk of cardiovascular disease and Type II Diabetes Mellitus. [1] **Why Weight Loss is the Correct Answer:** The hallmark of Metabolic Syndrome is **central (android) obesity** and insulin resistance. [1] Weight loss is actually a therapeutic goal and a protective factor, whereas **weight gain** (specifically an increased waist circumference) is a core diagnostic criterion. Therefore, weight loss is not a component of the syndrome. **Analysis of Incorrect Options:** * **Diabetes Mellitus Type II (Option A):** Insulin resistance is the pathophysiological backbone of Syndrome X. This leads to impaired glucose tolerance and eventually overt Type II Diabetes. [1] * **Dyslipidemia (Option B):** This is a broad term covering the lipid abnormalities found in the syndrome, characterized by a pro-atherogenic profile. * **High Triglycerides (Option C):** This is a specific diagnostic criterion (≥150 mg/dL). It is typically accompanied by **Low HDL** levels. **NEET-PG High-Yield Pearls:** To diagnose Metabolic Syndrome (per NCEP ATP III criteria), 3 out of the following 5 must be present: 1. **Waist Circumference:** >102 cm (M) or >88 cm (W). *Note: For Indians (Modified), it is >90 cm (M) and >80 cm (W).* 2. **Triglycerides:** ≥150 mg/dL. 3. **HDL Cholesterol:** <40 mg/dL (M) or <50 mg/dL (W). 4. **Blood Pressure:** ≥130/85 mmHg. 5. **Fasting Glucose:** ≥100 mg/dL. *Distinction:* Do not confuse "Syndrome X" (Metabolic) with **"Cardiac Syndrome X"** (Microvascular angina with normal epicardial coronaries).

Practice by Chapter

Diabetes Mellitus

Practice Questions

Thyroid Disorders

Practice Questions

Adrenal Gland Disorders

Practice Questions

Pituitary Disorders

Practice Questions

Calcium and Bone Metabolism

Practice Questions

Reproductive Endocrinology

Practice Questions

Lipid Disorders

Practice Questions

Endocrine Hypertension

Practice Questions

Multiple Endocrine Neoplasia

Practice Questions

Obesity and Metabolic Syndrome

Practice Questions

Neuroendocrine Tumors

Practice Questions

Endocrine Emergencies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free